Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Votorantim is a Brazilian family-owned investment holding company that manages a diversified portfolio of industrial, infrastructure, financial, energy, consumer, and environmental businesses. Its portfolio includes companies in cement and building materials, banking, aluminum, renewable energy, zinc and copper mining, orange juice, infrastructure, long steel, real estate, environmental services, growth equity, and a minority stake in pharmaceutical company Hypera Pharma. The company operates as a long-term capital allocator rather than a biotech, pharma, or healthcare operating company. Although Votorantim has exposure to healthcare through its investment in Hypera Pharma, Votorantim itself is not primarily a life sciences or healthcare company. It is best understood as a diversified private holding company with active portfolio management and governance oversight across multiple sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Votorantim.